Market Overview

UPDATE: JP Morgan Raises PT to $62 on Health Care REIT Post Q2

Share:
Related HCN
4 Big Dividend Stocks To Avoid In A Rising Interest Rate Environment
7 Biggest Price Target Changes For Friday
Livingston Group Asset Management CO (operating as Southport Capital Management) Buys Potash of ... (GuruFocus)

JP Morgan reiterated its Overweight rating on Health Care REIT (NYSE: HCN) and increased its price target from $61 to $62.

JP Morgan commented, "Our OW rating on HCN is based on a number of factors including our belief that the stock has above-average growth prospects relative to the health care sector, and we see valuation attractive based on discounted trading multiples and an above-average dividend yield."

Health Care REIT closed at $60.17 on Thursday.

Latest Ratings for HCN

DateFirmActionFromTo
Apr 2017Evercore ISI GroupDowngradesIn-LineUnderperform
Mar 2017Morgan StanleyUpgradesEqual-WeightOverweight
Jan 2017SunTrust Robinson HumphreyDowngradesBuyHold

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Reiteration Intraday Update Analyst Ratings

 

Related Articles (HCN)

View Comments and Join the Discussion!